Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 10, 2025
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire
·
April 10, 2025
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to receive treatment – at home, while ‘on …
Louisiana Mesothelioma Victims Center Recommends the Gori Law Firm to the Family of a Former Oil Refinery Worker with Mesothelioma or Lung Cancer in Louisiana-Expect Better Compensation Results
EIN Presswire
·
April 10, 2025
NEW ORLEANS, LA, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center highly recommends the Gori Law Firm to the family of a former oil refinery worker with recently diagnosed mesothelioma or lung cancer in …
TEC Mailing Solutions Launches 'AI First Step' Program for Agentforce, Leveraging Verify and Confirm™ for Salesforce®
EIN Presswire
·
April 10, 2025
TEC Mailing launches AI First Step, using Verify and Confirm™ to fix outdated Salesforce B2C addresses with real-time NCOA updates. SUN PRAIRIE, WI, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- TEC Mailing Solutions, a leading provider of address …
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Sea Shepherd Returns to Antarctica to Expose the Growing Threat of Krill Fishing
EIN Presswire
·
April 10, 2025
Sea Shepherd has returned to the Southern Ocean for its third consecutive campaign to monitor and expose the impact of industrial krill fishing in Antarctica. NETHERLANDS, April 10, 2025 /EINPresswire.com/ -- Sea Shepherd Returns to Antarctica to Expose …
Bierman Autism Centers Celebrates Grand Opening of West Orange, NJ Location with a Sensory-Friendly Barnyard Bash
EIN Presswire
·
April 10, 2025
Join us for a fun-filled Petting Zoo event on April 26—with crafts, treats, furry friends, and a special appearance by the Mayor of West Orange! WEST ORANGE, NJ, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- The barnyard is coming to town! Bierman …
Passing of former Chief Executive Officer, Dr. Loressa Cole
GlobeNewswire
·
April 10, 2025
SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE. Loressa was a beloved member of the American Nurses …
Harvard Bioscience Announces CFO Transition
GlobeNewswire
·
April 10, 2025
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effective …
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
GlobeNewswire
·
April 10, 2025
BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event to foster conversations about new funding models and …
Norwegian Cruise Line Holdings to Hold Conference Call on First Quarter 2025 Financial Results
GlobeNewswire
·
April 10, 2025
MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced today it will report first quarter 2025 financial results on …
Arcutis Announces Chief Financial Officer Transition
GlobeNewswire
·
April 10, 2025
WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, …
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
GlobeNewswire
·
April 10, 2025
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
April 10, 2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at- …
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 10, 2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025
GlobeNewswire
·
April 10, 2025
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the …
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
GlobeNewswire
·
April 10, 2025
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that two presentations and a panel …
Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact
GlobeNewswire
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
GlobeNewswire
·
April 10, 2025
SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
April 10, 2025
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …